Marketing of quality finished dosages in therapeutic segments such as OBG and Gynae, Fertility, Ortho, and Neuroscience.
Annual revenue $310,884 Latest available
Total funding - Funding intelligence
Employees 7 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Evasteo Pharmaceuticals

Evasteo Pharmaceuticals is a company. The company has 7 employees as of April 07, 2024. Evasteo Pharmaceuticals offers products and services including Finished Dosages and Therapeutic Products.

  • Employees 7 as on 07 Apr, 2024
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Legal Name Evasteo Pharmaceuticals Pvt. Ltd.
  • Jurisdiction Perinthalmanna, Kerala, India
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $310.88 K (USD)
    -3.54
    as on Mar 31, 2021
  • Net Profit
    $12.65 K (USD)
    126.12
    as on Mar 31, 2021
  • EBITDA
    $26.92 K (USD)
    49.03
    as on Mar 31, 2021
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    7

    as on Apr 07, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Evasteo Pharmaceuticals

Evasteo Pharmaceuticals offers a comprehensive portfolio of products and services, including Finished Dosages and Therapeutic Products.

Product name locked
Category locked
Primary

Quality finished dosages are marketed for various therapeutic segments.

Product name locked
Category locked
Locked

Products for segments like Fertility and Ortho are provided as part of pharmaceutical offerings.

Funding Insights of Evasteo Pharmaceuticals

Premium access

Detailed funding history for Evasteo Pharmaceuticals

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Evasteo Pharmaceuticals

Investments
Premium access

Investment portfolio details for Evasteo Pharmaceuticals

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Evasteo Pharmaceuticals

Premium access

Detailed financials for Evasteo Pharmaceuticals

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Evasteo Pharmaceuticals Comparisons

Evasteo Pharmaceuticals Primary company
Description
Marketing of quality finished dosages in therapeutic segment...
Location
-
Founded Year
-
Annual Revenue
$310.88 K (USD)
Net Profit
$12.65 K (USD)
EBITDA
$26.92 K (USD)
Employees
7
As of 2024
Premium access

Peer comparison for Evasteo Pharmaceuticals

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Evasteo Pharmaceuticals

Premium access

Detailed competitors of Evasteo Pharmaceuticals

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Evasteo Pharmaceuticals

Premium access

Complete news archive for Evasteo Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Evasteo Pharmaceuticals

As of Apr 07, 2024, the latest employee count at Evasteo Pharmaceuticals is 7.

Annual revenue of Evasteo Pharmaceuticals is $310.88K as on Mar 31, 2021.

Evasteo Pharmaceuticals is identified as a speciality pharmaceutical company that markets quality finished dosages across different therapeutic segments. Commitments are made to provide economical healthcare solutions, ensuring access is not denied to less privileged individuals. The company is noted for its efforts in social contributions, including environmental protection and initiatives in health and education. A team of highly talented individuals with proven track records is utilized in its operations. Focus is placed on being a model corporate citizen through these endeavors.

Evasteo Pharmaceuticals offers Finished Dosages and Therapeutic Products.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available